GE HealthCare (Nasdaq: GEHC) today announced the U.S. launch of Flyrcado™ (flurpiridaz F 18) injection at the 2025 American ...

The much-anticipated Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission tomography myocardial perfusion imaging agent for the detection of coronary artery ...

Danites take Micah’s idols and his priest, Jonathan; Danites attack Laish; moral degradation; the Levite’s concubine slain. And it came to pass in those days, when there was no king in Israel, that ...

Today, GE HealthCare announced the commercial launch of Flyrcado, a first-of-its-kind unit dose positron emission tomography myocardial perfusion imaging (PET MPI ... while simplifying the patient’s ...

In what is believed to be a world-first study, researchers from the University of Adelaide's Australian Dysautonomia and ...

Today, GE HealthCare announced the commercial launch of Flyrcado, a first-of-its-kind unit dose positron emission tomography myocardial perfusion imaging (PET MPI) agent, now available in select U ...

This is in part because lung cells can be driven to a profibrotic phenotype by multiple pathways that reinforce each other, so that targeting one pathway alone may not be effective to slow or stop ...

The many reasons a person may sleepwalk include genetics, sleep deprivation, stress, migraines, fever, breathing disorders, ...

GE HealthCare is also using ACC 2025 to highlight new AI-powered innovations for cardiac care: The latest version of CASE (Cardiac Assessment System for Stress Testing), powered by the company’s ...